The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

News

Life Science Analytics has partnered with IBC for the  Drug Discovery & Development Week 2009 on August 3-6 at the World Trade Center in Boston, MA
Life Science Analytics has partnered with IBC for the Drug Discovery & Development Week 2009 on August 3-6 at the World Trade Center in Boston, MA
06/23/2009

Life Science Analytics and IBC have teamed up to create a conference filter within the MedTRACK database to help delegates plan meetings and conduct due diligence on companies attending the event. The conference filter will be available Monday, June 22nd.

MedTRACK is the most comprehensive database of over 15,000 global private and public biomedical companies. Business development and financial professionals use MedTRACK to obtain data such as pipeline, partnering, and venture information on biomedical companies and products worldwide.

Decision support tools such as R&D intensity, Royalty Explorer, Worldwide Patent Wizard, and Management Contact Searching help you sift through the data and draw conclusions quickly.

Drug Discovery and Development Week in Boston, MA consists of five targeted, scientific conferences featuring practical strategies and forward-looking approaches to help attendees accelerate small molecules, antibody therapeutics, and oligonucleotide therapeutics from early discovery to the clinic. Please visit www.drugdisc.com for more information or to register.

If you are subscriber of MedTRACK and would like to view an online demonstration of the filter, login by clicking here. If you have any questions regarding this filter or how to use it, please contact us at customerservice@medtrack.com.

If you are not a subscriber of MedTRACK and would like to learn how the filter can assist you in preparing for the meeting, please click here.

IBC's Next Wave of Antibody Therapeutics August 3-5, 2009 - This conference brings together leading companies in the field of antibody conjugation and features emerging data on multiple antibody combinations projects, bi-specifics/multi-specifics, and new approaches to improve potency and efficacy.

Oligonucleotide Therapeutics - From Concept to Implementation August 3-5, 2009 - This conference addresses the question that is currently overwhelming the oligo drug discovery and development industry: Are We Leveraging on the Promise? If so, where are the proofs of implementation and how do we leapfrog this industry forward?

New Frontiers in Cancer Drug Development August 4-6, 2009 - This conference focuses on bridging the gap between discovery science, clinical science, and clinical trial design to improve translation from preclinical to clinical in order to increase cancer drug approval rates.

Targets in Context: Linking Targets to Disease August 4-6, 2009 - This conference looks specifically at how companies are currently linking targets to disease more effectively - through the use of innovative tools and approaches- and ultimately showing proof-of-concept in the clinic.

Drug Safety Strategies to De-Risk Compounds August 4-5, 2009 - This conference provides you with the latest data from preclinical models to predict hepatotoxicity, cardiotoxicity, and muscle toxicity that are having an impact today on decisions about whether to progress a compound or withdraw it from development.

If you are interested in registering for the Drug Discovery & Development week, complimentary access to MedTRACK is available for a limited time.

To register for one of the conferences during Drug Discovery & Development week or for a Full Access Pass to attend all of them, visit: www.drugdisc.com or call 800-390-4078.